We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network ... Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions. Show more
Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024 PR Newswire SECAUCUS, N.J., April 23, 2024 First quarter revenues of $2.37 billion, up 1.5% from...
Quest Diagnostics Adds p-tau217 Blood Biomarker Testing to Suite of Services Designed to Assess Risk and Help Aid Diagnosis of Alzheimer's Disease PR Newswire SECAUCUS, N.J., April 22, 2024...
Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay PR Newswire SECAUCUS, N.J., April 2, 2024 Aim to demonstrate whole...
Study in Frontiers in Neurology Affirms Amyloid Blood Test Can Help Identify Patients Who May Forgo Imaging Evaluation for Alzheimer's Disease PR Newswire SECAUCUS, N.J., March 26, 2024 Findings...
Quest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024 PR Newswire SECAUCUS, N.J., March 19, 2024 SECAUCUS, N.J., March 19, 2024 /PRNewswire/ -- Quest Diagnostics...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 7.74 | 6.11760986405 | 126.52 | 138.91 | 126.08 | 1583939 | 133.66536267 | CS |
4 | 1.53 | 1.15271604008 | 132.73 | 138.91 | 125.42 | 1097231 | 131.92012669 | CS |
12 | 7.8 | 6.16795824767 | 126.46 | 138.91 | 123.1825 | 1022438 | 128.72013466 | CS |
26 | 8.95 | 7.14228712792 | 125.31 | 143.6299 | 123.04 | 1011585 | 131.59829777 | CS |
52 | -11.52 | -7.90231856222 | 145.78 | 147.965 | 119.59 | 948118 | 132.25077517 | CS |
156 | 2.62 | 1.9902765117 | 131.64 | 174.16 | 119.59 | 1064235 | 138.53157024 | CS |
260 | 39.86 | 42.2245762712 | 94.4 | 174.16 | 73.01 | 1138155 | 126.03694459 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions